TG Therapeutics (TGTX)
NASDAQ:TGTX
Holding TGTX?
Track your performance easily

TG Therapeutics (TGTX) Stock News & Sentiment

1,700 Followers
New BRIUMVI® (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis
Premium
Press Releases
New BRIUMVI® (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis
5d ago
New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment
Premium
Press Releases
New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment
5d ago
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
Premium
Press Releases
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
18d ago
TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance
Premium
Press Releases
TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance
2M ago
TGTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
TGTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
TG Therapeutics Shareholders Back Growth at Annual Meeting
Premium
Company Announcements
TG Therapeutics Shareholders Back Growth at Annual Meeting
3M ago
TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Premium
Press Releases
TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
4M ago
More TGTX News >

News Score - Last 7 Days

Neutral
TGTX
Sector Average
Media Buzz
This Week6 articles
Weekly Average3 articles
News Sentiment
This Week50%
Sector Average60%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TGTX’s Media Buzz Sentiment?
6 articles about TGTX were published this week. In an average week, 3 articles are published.
    What is TGTX’s weekly average amount of articles?
    In an average week, 3 articles about TGTX are published.
      What is TGTX’s News Sentiment?
      50% of articles about TGTX were positive this week, compared to its sector average of 60%.
        Healthcare Stocks that are Trending in the News
        EWTXEdgewise Therapeutics
        ONCYOncolytics Biotech
        CAPRCapricor Therapeutics
        GNFTFGenfit
        PGNYProgyny
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis